| Disclaimer - Please see package insert for additional information and possible updates. The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Carimune ® NF, Nanofiltered:
|
||||||||||||||||||||||||||||
| DOSAGE FORMS AND STRENGTHS: Carimune® NF is available as a white lyophilized powder in 3, 6 and 12 g size vials. The only diluents which may be used to reconstitute the product are sterile (0.9%) Sodium Chloride Injection USP, 5% Dextrose, or Sterile Water. Each product presentation includes a package insert and the following components:
Storage and Handling Carimune® NF should be stored at room temperature not exceeding 30°C (86°F). The preparation should not be used after the expiration date printed on the label. SOURCE: FDA: Proper Name: Immune Globulin Intravenous (Human) Tradename: Carimune ® NF, Nanofiltered Manufacturer: CSL Behring AG, License #1766 Package Insert (PDF - 279 KB) - October 2008 |
||||||||||||||||||||||||||||
Flebogamma® DIF 5% and 10%:
|
||||||||||||||||||||||||||||
| DOSAGE FORMS AND STRENGTHS: Flebogamma 5% DIF is supplied in single-use, individually laser etched vials containing the labeled amount of functionally active IgG. The following presentations of Flebogamma 5% DIF are available:
Each vial has an integral suspension band and a label with two peel-off strips showing the product name and lot number. Flebogamma 5% DIF may be stored at room temperature at 2 to 25 ºC (36 to 77 ºF) for 24 months, as indicated by the expiration date printed on the outer carton and container label. Discard after expiration date. Do not freeze. Keep Flebogamma 5% DIF in its original carton to protect it from light. SOURCE: FDA: Proper Name: Immune Globulin Intravenous (Human) Tradename: Flebogamma DIF 5% Manufacturer: Instituto Grifols, SA, License #1181 Indication: Replacement therapy in primary (inherited) humoral immune deficiency disorders Product Information |
||||||||||||||||||||||||||||
GAMASTAN S/D®:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: GamaSTAN S/D is supplied in 2 mL and 10 mL single dose vials. GamaSTAN S/D is preservative-free and latex-free.
STORAGE Store at 2–8°C (36–46°F). Do not freeze. Do not use after expiration date. SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
GAMMAGARD LIQUID®:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: GAMMAGARD LIQUID is supplied in single use bottles containing the labeled amount of functionally active IgG. The packaging of this product is not made with natural rubber latex. The following presentations of GAMMAGARD LIQUID are available:
Do not freeze. Refrigeration: 36 months storage at temperature 2°to 8°C (36° - 46°F). Room Temperature: 12 months storage at room temperature 25°C, (77°F) within the first 24 months of the date of manufacture. See package insert for detailed storage information. SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
GAMMAGARD S/D®:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: GAMMAGARD S/D is supplied in single use bottles containing the labeled amount of functionally active IgG. The following presentation of GAMMAGARD S/D is available:
Each bottle of GAMMAGARD S/D is furnished with a suitable volume of Sterile Water for Injection, USP, a transfer device and an administration set which contains an integral airway and a 15 micron filter. GAMMAGARD S/D is to be stored at a temperature not to exceed 25ºC (77ºF) for 24 months. Do not Freeze. SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
GAMMAKED™®:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: GAMMAKED is supplied in single-use, tamper evident vials (shrink band) containing the labeled amount of functionally active IgG. The three larger vial size labels incorporate integrated hangers. The components used in the packaging for GAMMAKED are latex-free. GAMMAKED is supplied in the following sizes:
DO NOT FREEZE GAMMAKED may be stored for 36 months at 2–8°C (36–46°F) from the date of manufacture, AND product may be stored at temperatures not to exceed 25°C (77°F) for up to 6 months anytime during the 36 month shelf life, after which the product must be immediately used or discarded. Do not use after expiration date. SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
GAMMAPLEX®:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: Gammaplex is supplied in a single use, clear Type II glass bottle, closed with a stopper (13% natural rubber) and oversealed with a tamper-evident cap. The following presentations of Gammaplex are available:
Each vial has a label with a peel-off strip showing the product name and batch number. When stored between 2 °C [35.6 °F] and 25 °C [77 °F]), Gammaplex has a shelf life of 24 months, as indicated by the expiration date printed on the outer carton and vial label. Keep Gammaplex in its original carton to protect it from light. DO NOT FREEZE. SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
GAMUNEX®-C:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: GAMUNEX-C is supplied in single-use, tamper evident vials (shrink band) containing the labeled amount of functionally active IgG. The three larger vial size labels incorporate integrated hangers. The components used in the packaging for GAMUNEX-C are latex-free. GAMUNEX-C is supplied in the following sizes:
DO NOT FREEZE GAMUNEX-C may be stored for 36 months at 2 - 8°C (36 - 46°F) from the date of manufacture, AND product may be stored at temperatures not to exceed 25°C (77°F) for up to 6 months anytime during the 36 month shelf life, after which the product must be immediately used or discarded. Do not use after expiration date. SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
Hizentra®:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: Hizentra is supplied in a single-use, tamper-evident vial containing 0.2 grams of protein per mL of preservative-free liquid. Each product presentation includes a package insert and the following components:
SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
OCTAGAM®:
|
||||||||||||||||||||||||||||
DOSAGE FORMS AND STRENGTHS: Octagam 5% liquid is supplied in 1.0 g, 2.5 g, 5 g, 10 g or 25 g single use bottles.
Octagam 5% liquid is not supplied with an infusion set. If a filtered infusion set is used (not mandatory), the filter size must be 0.2 – 200 microns. Components used in the packaging of Octagam 5% liquid are latex-free. Octagam 5% liquid may be stored for 24 months at +2°C to + 25°C (36°F to 77°F) from the date of manufacture. Do not use after expiration date. Do not freeze. Frozen product should not be used. Any unused product or waste material should be disposed of in accordance with local requirements. SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
PRIVIGEN®:
|
||||||||||||||||||||||||||||
|
DOSAGE FORMS AND STRENGTHS: Privigen is supplied in a single-use, tamper-evident vial containing the labeled amount of functionally active IgG. Each product presentation includes a package insert and the following components:
SOURCE: U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health, Health & Human Services Link to package insert. |
||||||||||||||||||||||||||||
Reference(s) |
||||||||||||||||||||||||||||
|
National Institutes of Health, U.S. National Library of Medicine,
DailyMed Database. Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates. A local search option of this data can be found here. |
||||||||||||||||||||||||||||
Disclaimer |
||||||||||||||||||||||||||||
|
Listed dosages are for - Adult patients ONLY. PLEASE READ THE
DISCLAIMER CAREFULLY BEFORE
ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE
TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.
GlobalRPH does not directly or indirectly practice medicine or provide
medical services and therefore assumes no liability whatsoever of any
kind for the information and data accessed through the Service or for
any diagnosis or treatment made in reliance thereon. David F. McAuley, Pharm.D., R.Ph. GlobalRPh Inc. |
||||||||||||||||||||||||||||
